Elelyso: A New Therapeutic Option for Patients with Gaucher Disease

Product News   May 11, 2012

 
Elelyso: A New Therapeutic Option for Patients with Gaucher Disease
 
 
FURTHER INFORMATION
 
 
 

Related Product News

TriNetX Unveils Natural Language Processing Service

Product News

Combines EMR and NLP data to deliver the industry’s most comprehensive data set for cohort analysis and site selection.

READ MORE

Bio-Rad Releases First CE-IVD Digital PCR Test for Monitoring Chronic Myeloid Leukemia Response to Therapy

Product News

QXDx BCR-ABL %IS Kit Achieves Highest Sensitivity for Detecting Disease Remission in Patients with Chronic Myeloid Leukemia.

READ MORE

QIAGEN Advances Precision Medicine

Product News

First bioinformatics solution integrating new AMP/ASCO/CAP standards for NGS cancer testing to confidently and quickly report clinical relevance of somatic mutations.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE